CVE-2022-48223

Name: CVE-2022-48223
Creator: NVD / NIST
Published: 2023-04-04T16:15:07.187+00:00
License: https://creativecommons.org/publicdomain/zero/1.0/

MEDIUMCVSS 6.7/10EPSS 0.11%

Last modified Jun 17, 2026

CVE-2022-48223 is a medium-severity vulnerability rated 6.7/10 on the CVSS scale. An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During SDK repair, certutil.exe is called by the Acuant installer to repair certificates. EPSS estimates a 0.11% chance of exploitation in the next 30 days.

Description

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During SDK repair, certutil.exe is called by the Acuant installer to repair certificates. This call is vulnerable to DLL hijacking due to a race condition and insecure permissions on the executing directory.

Metrics

CVSS 3.1

6.7/10

CVSS:3.1/AV:L/AC:H/PR:L/UI:R/S:U/C:H/I:H/A:H

EPSS Probability

0.11%

1.8th percentile

Probability of exploitation in the next 30 days. Learn more

Weakness Enumeration

CWE-427

Affected Software

Vendor	Product	Versions
Gbgplc	Acuant Acufill Sdk	< 10.22.02.03

References

https://acuant.comNot Applicable
https://hackandpwn.com/disclosures/CVE-2022-48223.pdfThird Party Advisory
https://acuant.comNot Applicable
https://hackandpwn.com/disclosures/CVE-2022-48223.pdfThird Party Advisory

Timeline

Published: Apr 4, 2023
Last Modified: Jun 17, 2026
Status: Modified

Frequently Asked Questions

What is CVE-2022-48223?

How severe is CVE-2022-48223?

CVE-2022-48223 has a CVSS score of 6.7/10 (MEDIUM severity). The EPSS model estimates a 0.11% probability of exploitation in the next 30 days.

How do I fix CVE-2022-48223?

Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

Are you affected by CVE-2022-48223?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST